Wyden letter urges Centers for Medicare & Medicaid Services to “conduct immediate oversight and rigorous regulatory enforcement of specific Medicare Part D program requirements for plan sponsors and their PBMs.”
NACDS also is urging Congress to enact in the 118th Congress PBM reforms in Medicare, Medicaid and the commercial markets: all levels and branches of government must do their jobs.
“Confronting the PBMs’ self-enriching tactics requires state and federal legislators and policymakers to do their part.”
The New York Times publishes first article in a series: “The Middlemen: The Opaque Industry Secretly Inflating Prices for Prescription Drugs; Pharmacy benefit managers are driving up drug costs for millions of people, employers, and the government.”
PBMs represent a “staggering national problem.”
Urges Congress: no further delays in enacting bipartisan reforms to reduce Americans’ drug costs and to protect access to pharmacies and prescribed medications.
H. 233 includes important reforms that will help curb PBM tactics threatening Vermont patients and the pharmacies on which they rely.
Responds to RFI from Department of Justice, Department of Health and Human Services, and Federal Trade Commission.
The Massachusetts advertising campaign comes as part of NACDS’ broader advocacy work in collaboration with in-state partners.
NACDS participated on May 30 in a panel discussion hosted by thINc360 – The Healthcare Innovation Congress, which focused on how pharmacies and other healthcare stakeholders can help broaden the impact of food is medicine programs through technology, partnerships, and evidence-based interventions.
NACDS is calling attention to a new policy paper published by the Global Healthy Living Foundation and authored by Robert Popovian, PharmD, MS, Founder, Conquest Advisors, and GHLF’s Chief Science Policy Officer.
